Both in Pharmaceuticals
Acurx Pharmaceuticals vs Longeveron
Over the past year ACXP returned −83.0% and LGVN returned −80.8%; their daily moves had a correlation of 0.06.
ACXP −83.0% LGVN −80.8%Growth of $1, one year, split-adjusted
| Metric | ACXP | LGVN |
|---|---|---|
| Price | $1.07 | $1.78 |
| Market cap | $5.9M | $5.7M |
| Today | +0.94% | +2.89% |
| 1 month | −18.0% | −34.6% |
| 6 months | −45.7% | −79.4% |
| Year to date | −57.0% | −64.8% |
| 1 year | −83.8% | −80.6% |
| Revenue growth (YoY) | — | −9.2% |
| Gross margin | — | 63.4% |
| Net margin | — | −2116.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.8× |
| Net cash | $10.7M | $10.1M |
| Dividend yield | — | — |
| Volatility (60d) | 60.4% | 708.8% |
| Short % of float | 1.8% | 2.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).